Free Trial

Feedback (FDBK) Competitors

Feedback logo
GBX 13.25 0.00 (0.00%)
As of 08/22/2025 10:47 AM Eastern

FDBK vs. COG, INHC, IQAI, TRLS, DVRG, SENS, EMIS, CRW, INS, and KOO

Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Cambridge Cognition (COG), Induction Healthcare Group (INHC), IQ-AI (IQAI), Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), and Kooth (KOO). These companies are all part of the "health information services" industry.

Feedback vs. Its Competitors

Feedback (LON:FDBK) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

In the previous week, Feedback's average media sentiment score of 0.00 equaled Cambridge Cognition'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
Cambridge Cognition Neutral

Cambridge Cognition has higher revenue and earnings than Feedback. Cambridge Cognition is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£3.88M1.49-£10.84M-£24.74-0.54
Cambridge Cognition£15.64M0.72-£1.58M-£3.76-7.18

Cambridge Cognition has a net margin of -10.07% compared to Feedback's net margin of -279.16%. Feedback's return on equity of -39.71% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-279.16% -39.71% -22.99%
Cambridge Cognition -10.07%-68.83%-0.30%

53.2% of Feedback shares are owned by institutional investors. Comparatively, 35.2% of Cambridge Cognition shares are owned by institutional investors. 10.8% of Feedback shares are owned by company insiders. Comparatively, 29.9% of Cambridge Cognition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Feedback has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.

Summary

Cambridge Cognition beats Feedback on 6 of the 11 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£5.81M£340.22M£5.76B£3.22B
Dividend Yield4.56%5.90%4.41%5.04%
P/E Ratio-0.54366.5131.10164.64
Price / Sales1.49218.64432.51310,107.36
Price / Cash1.1247.1437.7327.93
Price / Book0.235.119.535.90
Net Income-£10.84M-£15.55M£3.26B£5.89B
7 Day Performance1.92%1.04%2.10%48.38%
1 Month Performance-6.98%1.53%2.81%55.09%
1 Year Performance-76.34%7.07%30.56%135.37%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 13.25
flat
N/A-75.0%£5.81M£3.88M-0.5424
COG
Cambridge Cognition
N/AGBX 25.30
+1.2%
N/A-39.3%£10.59M£15.64M-6.7280
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A-2.5%£9.00M£12.57M-1.7674
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-33.3%£1.77M£538.19K-13.676Gap Up
TRLS
Trellus Health
N/AGBX 0.72
-4.3%
N/A-48.0%£1.39M£65.83K-0.2131Gap Down
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
N/AGBX 2,220.06
-0.9%
GBX 2,725
+22.7%
-2.2%£953.88M£230.77M82.02734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
3.0268 of 5 stars
GBX 157.20
+0.1%
GBX 456.67
+190.5%
-50.6%£57.70M£50.72M14.77478

Related Companies and Tools


This page (LON:FDBK) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners